Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 3Phase 3 2Phase 2/3 2

Status

Completed 4Unknown 1Terminated 1

Sponsor Class

OTHER 14INDUSTRY 6

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 687Breast Neoplasms 585Neoplasms 468Colorectal Neoplasms 300Prostatic Neoplasms 263Neoplasm Metastasis 257Melanoma 242Ovarian Neoplasms 228Recurrence 216Lung Neoplasms 203Multiple Myeloma 196Lymphoma, Non-Hodgkin 155Pancreatic Neoplasms 154Leukemia, Myeloid, Acute 142Carcinoma, Hepatocellular 141Stomach Neoplasms 137Lymphoma 131Carcinoma, Renal Cell 128Glioblastoma 118Squamous Cell Carcinoma of Head and Neck 113Head and Neck Neoplasms 113Lymphoma, Follicular 106Leukemia, Lymphocytic, Chronic, B-Cell 99Small Cell Lung Carcinoma 96Lymphoma, Large B-Cell, Diffuse 96Leukemia 96Brain Neoplasms 91Carcinoma 82Uterine Cervical Neoplasms 77Triple Negative Breast Neoplasms 73

Interventions

Infliximab 1Gemcitabine 1EOM613 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × Anorexia × Clear all
NCT05546476 2026-06-03

PROACC-1

Pfizer

Phase 2 Completed
187 enrolled 24 charts
GastrointestinalThoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Weight Loss

NCT00219817 2013-09-02

Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss

Helsinn Therapeutics (U.S.), Inc

Phase 2 Completed
80 enrolled

Anorexia, Cachexia

NCT00527319 2013-01-30

VT-122

Vicus Therapeutics

Phase 2 Completed
37 enrolled 9 charts

Anorexia, Cachexia

NCT01206335 2012-11-27

Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia

Ohr Pharmaceutical Inc.

Phase 2 Unknown
20 enrolled

Anorexia, Fatigue, Weight Loss

NCT00060502 2011-05-17

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia

Centocor, Inc.

Phase 2 Completed
73 enrolled
Classical hematologyGastrointestinal

Anemia, Anorexia, Cachexia, Pancreatic Neoplasms

NCT00535015 2008-07-22

Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer

Anaborex

Phase 2 Terminated
70 enrolled
Thoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡